Table 3.
Comparison of demographic and medical variables with lung computed tomography abnormalities.
| Lung computed tomography abnormalities |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| Ground glass |
Nodular |
Consolidation |
Opacity |
||||||
| n,% |
P-value OR (95% CI) |
n,% |
P-value OR (95% CI) |
n,% |
P-value OR (95% CI) |
n,% |
P-value OR (95% CI) |
||
|
Age (n, %) |
< 60 (n = 79) |
59 (74.7) | > 0.05 1.21 (0.98-1.50) |
08 (10.1) | > 0.05 0.99 (0.86-1.02) |
37 (46.8) |
> 0.05 1.08 (0.80-1.46) |
24 (30.4) | > 0.05 1.20 (0.95-1.52) |
| ≥ 60 (n = 81) |
50 (51.7) | 03 (3.7) | 41 (50.6) | 34 (42.0) |
|||||
|
Variants (n, %) |
Alpha (n=26) |
24 (92.3) |
< 0.05 | 08 (30.8) |
< 0.001 | 04 (15.4) |
< 0.001 | 01 (3.8) |
< 0.001 |
| Delta (n=98) |
66 (67.3) |
0 (0.0) |
63 (64.3) |
42 (42.9) |
|||||
| Omicron (n = 36) |
19 (52.8) |
03 (8.3) |
11 (30.6) |
15 (41.7) |
|||||
| Vaccine | None (n=105) |
72 (68.6) | > 0.05 | 09 (8.6) | > 0.05 | 52 (49.5) | > 0.05 | 34 (32.4) | > 0.05 |
| 1 dose (n = 17) |
12 (70.6) | 00 (0.0) | 11 (64.7) | 06 (35.3) | |||||
| ≥2 doses (n = 38) |
25 (65.8) | 02 (5.3) | 15 (39.5) | 18 (47.4) | |||||
| Oxygen therapies | Not used (n = 68) |
52 (76.5) | > 0.05 | 08 (11.8) | > 0.05 | 18 (26.5) | < 0.001 | 18 (26.5) | < 0.05 |
| Mask cannula (n = 68) |
40 (58.8) | 02 (2.9) | 47 (69.1) | 32 (47.1) | |||||
| Ventilator (n = 24) |
17 (70.8) | 01 (4.2) | 13 (54.2) | 08 (33.3) | |||||
| Severities | Non severe (n = 72) |
54 (75.0) | > 0.05 0.83 (0.68-1.03) |
08 (11.1) |
> 0.05 1.09 (0.99-1.19) |
17 (23.8) |
< 0.001 2.94 (1.89-4.56) |
21 (29.2) |
> 0.05 0.82 (0.65-1.03) |
| Severe (n = 88) |
55 (62.5) |
03 (3.4) |
61 (69.3) |
37 (42.0) |
|||||
| Treatment outcomes | Survive (n = 140) |
95 (67.9) | > 0.05 1.07 (0.53-2.18) |
10 (7.1) | > 0.05 0.98 (0.88-1.09) |
66 (47.1) | > 0.05 1.32 (0.76-2.31) |
49 (35.0) | > 0.05 1.18 (0.78-1.79) |
| Death (n = 20) |
14 (70.0) | 01 (5.0) | 12 (60.0) | 09 (45.0) | |||||
CI, confidence interval; OR, odds ratio.